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Cellular inhibitors of apoptosis proteins (cIAPs) are
essential regulators of cell death and immunity. The
corresponding contributions of IAPs to infectious
disease outcomes are relatively unexplored. We
find that mice deficient in cIAP2 exhibit increased
susceptibility and mortality to influenza A virus infec-
tion. The lethality was not due to impaired antiviral
immune functions, but rather because of death-
receptor-induced programmed necrosis of airway
epithelial cells that led to severe bronchiole epithelial
degeneration, despite control of viral replication.
Pharmacological inhibition of RIPK1 or genetic dele-
tion of Ripk3, both kinases involved in programmed
necrosis, rescued cIAP2-deficient mice from influ-
enza-induced lethality. Genetic deletion of the
death receptor agonists Fas ligand or TRAIL from
the hematopoietic compartment also reversed the
susceptibility of cIAP2-deficient mice. Thus, cIAP2-
dependent antagonism of RIPK3-mediated pro-
grammed necrosis critically protects the host from
influenza infection through maintenance of pulmo-
nary tissue homeostasis rather than through path-
ogen control by the immune system.
INTRODUCTION
Infection with influenza A virus causes an acute, highly conta-
gious respiratory illness that triggers cell death of infected cells
and airway epithelial destruction. Cell death is an integral part
of the immune response to influenza (Yatim and Albert, 2011).
For example, apoptosis is thought to clear infected cells to limit
viral propagation and to control runaway immunopathological
responses. However, inappropriate cell death can disrupt the
architecture and integrity of the bronchoalveolar network,
leading to barrier disruption and compromised arterial bloodCell Hoxygenation following lethal influenza infection in the mouse
model (Sanders et al., 2013). In humans, both necrosis and
apoptosis of distal pulmonary epithelia were described as a
classical feature of H5N1 or H1N1 influenza-induced acute res-
piratory distress syndrome (Korteweg and Gu, 2008; Mauad
et al., 2010). Viruses can trigger not only apoptosis but also an
alternative form of caspase-independent cell death called
programmed necrosis (or necroptosis). Necroptosis, which
depends on the kinase activity of the receptor-interacting
proteins (RIPK)1 and RIPK3 (He et al., 2009), is emerging as a
backup host defense mechanism that restricts virus persistence
in instances when apoptosis is disabled by the virus, as exempli-
fied by vaccinia virus or the murine cytomegalovirus (Cho et al.,
2009; Upton et al., 2010, 2012). Whether necroptosis plays a
similar role in host resistance to RNA viruses is not clear (Berger
and Danthi, 2013). While cell death is effective in curbing viral
spread by removing intracellular replication niches, it places a
cost on the host by exacerbating tissue injury following infection
and, as such, must be tightly controlled.
Apoptosis and necroptosis are complementary cell death
pathways controlled by common signaling adaptors, kinases,
caspases, and ubiquitin ligases. Of these, the cellular inhibitors
of apoptosis proteins (cIAPs), through their E3 ubiquitin ligase
activity, are critical upstream regulators of both forms of cell
death (Vanlangenakker et al., 2011b). However, the exact con-
tribution of individual IAP in antagonizing cell death in vivo
has been difficult to ascertain because of their apparent
functional redundancy in mammals. Indeed, Birc2(cIAP1)/,
Birc3(cIAP2)/ and Birc4(XIAP)/ mice are all viable and
display limited cell-death-related phenotypes in opposition to
Birc2/Birc4/ orBirc2/Birc3/mice that die by embryonic
day E10.5 (Moulin et al., 2012). This lethality was delayed to
some extent by codeletion of Ripk1 or Ripk3, highlighting that
cIAPs function in vivo as arbiters of cell fate through repression
of RIP kinase activity. Mechanistically, cIAP1 and cIAP2 mediate
the ubiquitination of RIPK1, which prevents the formation of a
large 2 MDa RIPK1-dependent platform, named the ‘‘ripopto-
some’’ (also referred to as necrosome) (Feoktistova et al.,
2011; Tenev et al., 2011). In response to different stressors
such as viral infections or engagement of death receptorsost & Microbe 15, 23–35, January 15, 2014 ª2014 Elsevier Inc. 23
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leads to caspase-independent necrotic cell death. The cIAPs
have also been shown to exert key functions in the regulation
of innate immunity. Notably, they are required for cytokine and
chemokine production by NOD1 and NOD2 (Bertrand et al.,
2009), mediate MAPK activation by TLR4 (Tseng et al., 2010),
enhance caspase-1 activation by the inflammasome (Labbe´
et al., 2011), and carry out ubiquitination steps downstream of
RIG-I signaling (Mao et al., 2010). Although cIAPs are recognized
as effectors in cell death and immune signaling pathways, there
is an incomplete understanding of which of these two defense
processes are principally regulated by cIAPs during infectious
disease, and even less is known of their involvement in protec-
tion against viruses.
Here we report that deletion of cIAP2 leads to marked loss of
lung epithelium and enhanced susceptibility to influenza-virus-
induced acute lung injury. This is not a result of any defects in
antiviral immunity. Rather, cIAP2 acts to calibrate the activation
threshold of necroptosis in pulmonary epithelial cells at the level
of its regulation of the stoichiometry of FLIP isoforms and the
formation of a RIPK3 necrosome complex that is assembled in
response to DR signaling during infection.
RESULTS
Enhanced Susceptibility to Influenza Virus Infection in
cIAP2-Deficient Mice despite Virus Control
To investigate whether cIAP2 influences immunity, inflammation,
and/or pulmonary tissue homeostasis to viral infections, wild-
type (WT) and Birc3/ mice were infected intranasally with a
sublethal dose of H1N1 influenza A virus Puerto Rico/8/34 strain
(referred to as PR/8) and monitored for pathologic and virologic
parameters. After exposure to PR/8, over 75%ofWTmice recov-
ered by day 13 postinfection (p.i.) (Figure 1A), despite a loss of
25% of their original body weight (Figure 1B). In contrast,
Birc3/ mice had increased mortality (Figure 1A; p % 0.0001)
and considerably greater weight loss (Figure 1B), despite both
genotypes not exhibiting differences in viral replication (Fig-
ure 1C) or viral titers in the lung (Figure 1D). To determine the
cellular compartment in which cIAP2 expression was required
for host protection, we generated bone marrow chimeras in
which only the hematopoietic (WT/Birc3/) or radio-resistant
compartment (Birc3//WT) expressed cIAP2. The failure of
WT marrow to rescue Birc3/mice from PR/8-induced lethality
suggested that cIAP2 is primarily required in the radio-resistant
compartment (Figure 1E). Notwithstanding the ubiquitous role
of the cIAPs in immune signaling, the lethality of Birc3/ mice
after PR/8 infection was not linked to appreciable defects in
inflammation or the innate and adaptive immune responses (Fig-
ure S1 available online; related to Figure 1). With the exception of
CXCL1, which was moderately higher in Birc3/ mice (Fig-
ure S1A; p < 0.05), whole-lung levels of IL-1b, IL-6, CCL2, and
IFN-lwere similar between genotypes on all daysmeasured (Fig-
ure S1A). Secretion of these cytokines into the bronchoalveolar
lavage fluid (BALF) on day 3 p.i. was also not different between
genotypes (Figure S1B). Correspondingly, there was similar
recruitment of leukocytes into the lung on days 3 and 7 p.i. (Fig-
ure S1C) and the frequencies of macrophages, neutrophils, NK
cells, B cells, and T cells in the infected lung were not different24 Cell Host & Microbe 15, 23–35, January 15, 2014 ª2014 Elsevier I(Figure S1D). Secretion of IFN-b and CXCL10 (two antiviral de-
fense genes) by BMDCs from Birc3/ mice was equivalent to
that of WT BMDCs when infected in vitro with Sendai virus or
transfected with 50 triphosphate dsRNA (Figures S1E and S1F),
indicating that there is no intrinsic defect in RIG-I signaling in
the absence of cIAP2. Indeed, secreted levels of IFN-a and
CXCL10 into the BALF of WT and Birc3/ mice were similar
between genotypes (Figures 1F and 1G). Consistent with intact
antiviral immune responses capable of controlling PR/8 infection,
the total number of influenza DbNP366-specific CD8+ T cells pre-
sent in the BALF, lung parenchyma and spleen of Birc3/ mice
was similar to that of WT mice (Figure S1G–S1J). Additionally,
influenza-specific CD8+ T cells from Birc3/ mice were as
capable of producing IFN-g as those ofWTmice upon ex vivo re-
stimulationwith influenza peptides (Figure S1K). Finally, although
influenza-specific IgG antibody levels were reduced in the sera of
Birc3/ mice on days 7 and 11 p.i. (Figure S1L), this decrease
did not appear to influence viral clearance in this genotype, as
the lung viral titers from the same animals were not increased
compared to WT mice (Figures 1D and 2E).
Impaired Airway Integrity Following Influenza Infection
in Birc3–/– Mice
Histopathological examination of lung sections from naive mice
(Figure 2A), compared to those from infected WT mice on days
7 and 11 p.i. (Figure 2B), revealed peribronchiolar inflammation
and epithelial hyperplasia characteristic of ongoing tissue dam-
age and repair responses during PR/8 infection (Monticelli et al.,
2011). In contrast, lungs from infected Birc3/ mice had large
regions of hemorrhage, as well as more pronounced bronchiolar
epithelial damage with extensive sloughing of the epithelial lining
(Figure 2B) and, in many cases, obstruction of the airway by
exudate and dead cells in the bronchiolar lumen. These histo-
pathological features were unlikely to be due to preexisting
differences in the airway epithelium of Birc3/ mice, as their
bronchioles prior to infection had normal epithelial cell lining
similar to naive WT mice (Figure 2A). The observed changes to
the airway architecture of Birc3/ mice following infection
were linked to impaired epithelial integrity by day 11 p.i.
compared to WT mice, as measured by increased translocation
into the BALF of intravenously injected BSA-fluorescein isothio-
cyanate (FITC) (Figure 2C). Probing for the epithelial cell marker
CD326 confirmed that a fraction of the cells shed into the bron-
chiolar lumen were of epithelial origin and that this phenomenon
was generally confined to Birc3/ mice (Figure 2D). Moreover,
there was no significant difference in the pathogen burden, as
measured by immunofluorescence staining for PR/8 antigens
(Figure 2E), in the samemice that showed loss of epithelial integ-
rity (Figures 2B and 2C), reinforcing the idea that lethality and
tissue damage are independent of viral control. Collectively,
these observations indicate a role for cIAP2 in maintaining tissue
homeostasis in the lung following acute viral infection.
Caspase-Independent Cell Death of Birc3–/– Airway
Epithelial Cells
Because histological analysis of hematoxylin and eosin
(H&E)-stained lung sections taken from Birc3/ mice revealed
signs of necrotizing bronchitis (Figure 2), we turned our attention
to the effect cIAP2 deletion has on cell death following PR/8nc.
Figure 1. Nonhematopoietic Expression of cIAP2 Is Required for Survival after Pulmonary Challenge with Influenza A Virus
(A and B) (A) Survival and (B) body weight changes of PR/8-infected Birc3/ (n = 20) and WT (n = 33) mice compared to mock-inoculated WT mice (n = 15)
(p < 0.0001; log rank). Data are pooled from two independent experiments; each line in (B) represents an individual mouse.
(C) Influenza M1 gene expression (mean ±SEM) by qPCR at 3 or 5 days p.i. Data are pooled from two independent experiments (n = 8–10 mice per time point).
(D) Viral titers were quantified on 3, 7, and 11 days p.i. by plaque assay (mean ±SD; n = 3–4 mice per genotype per time point).
(E) Survival rate of chimeric mice after infection with PR/8 virus. Log rank statistical significance is depicted in the table below the graph.
(F and G) BALF IFN-a (F) and CXCL10 (G) during infection. Data are pooled from two independent experiments (mean ±SEM; n = 8–10mice per genotype per time
point). See also Figure S1.
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the expression of Fasl, Tnfsf10, and Tnf in the lung was induced
by infection in both Birc3/ andWTmice but that Birc3/mice
exhibited higher levels of these transcripts than WT mice at later
time points (Figure 3A). However, when we examined apoptotic
caspase activation by immunofluorescence and immunoblot
analysis in lungs of infected Birc3/ mice, we found reduced
levels of processed caspase-3 (Figures 3B and 3C) and cas-
pase-8 (Figure 3C) compared to WT controls. This difference
was observed despite the presence of inflammation, asCell Hmeasured by NF-kB2 activation (Figure 3C). Correspondingly,
the proportion of apoptotic pulmonary epithelial cells
was reduced in Birc3/mice compared to WTmice, as demon-
strated by fluorescence-activated cell sorting (FACS)
quantification of active caspase-3 in dying CD326+CD45
CD31Ter119 airway epithelial cells (AECs) isolated from colla-
genase-digested lungs of PR/8 infected mice at day 7 p.i. (Fig-
ures 3D–3F). Analysis of tissue sections by immunofluorescence
showed that CD326+ AECs in the bronchiole lumen of Birc3/
mice were negative for active caspase-3 (Figure 3G). Noost & Microbe 15, 23–35, January 15, 2014 ª2014 Elsevier Inc. 25
Figure 2. Respiratory Tissue Damage Following Influenza Infection in Birc3–/– Mice
(A and B) H&E sections through themain bronchiole of the left lobe showing pulmonary hemorrhage (star) and epithelial shedding (black arrows) and degeneration
(black arrow head). Scale bar indicates 25 mm. Insets correspond to the boxed regions. Images shown are representative of four to five mice per genotype for
three independent experiments.
(C) BSA-FITC arbitrary fluorescent units in BALF (mean ±SD; n = 4–5 mice per genotype per time point). One-way ANOVA with Bonferroni’s post-test (*p < 0.05).
(D and E) Epithelial cell marker CD326 (D) or PR/8 virus antigens (E) immunofluorescence. White arrowheads point to epithelial cell shedding. Images shown are
representative of two to three mice from two independent experiments. Scale bar indicates 50 mm.
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CD31+CD45 lung endothelial cell (Figure S2A, related to Fig-
ure 3) apoptosis could be detected in infected Birc3/ mice
compared with WT mice, suggesting that modulation of cell
death in the absence of cIAP2 is cell-type specific.
The NLRP3-caspase-1 inflammasome has been reported to
protect the host from influenza-induced acute injury to the respi-
ratory epithelium (Thomas et al., 2009). On the other hand,
hyperactivation of the inflammasome pathway through loss of
Ripk2 was recently linked to influenza-induced airway neutro-
philia, necrotic cell death, tissue damage, and lethality (Lupfer
et al., 2013). Because cIAP2 is required for efficient activation
of caspase-1 (Labbe´ et al., 2011) and RIPK2 ubiquitination (Ber-
trand et al., 2009), we next asked what role, if any, activation of
caspase-1 and its ensuing pyroptotic cell death program might
play in the lethality to influenza in Birc3/mice. At the sublethal
dose of PR/8 used in this study, Casp1//Casp11/ and
Nlrp3/ mice proved as resistant to infection as WT mice (Fig-
ure S2B, related to Figure 3). In contrast, deficiency in either
the inflammasome adaptor ASC or overall IL-1 signaling26 Cell Host & Microbe 15, 23–35, January 15, 2014 ª2014 Elsevier I(Il1r1/) impaired protection to PR/8 infection (Figure S2B).
However, the frequency of necrotic AECs in both of these geno-
types was either equivalent to or lower than WT mice (Fig-
ure S2C), suggesting that the pathogenic mechanisms at play
in Asc/ and Il1r1/ mice are distinct from those observed in
Birc3/ mice and are acting independently of the canonical
inflammasome pathway in this model. Moreover, contrary to
Birc3/ mice, infection of Ripk2/ mice resulted in slightly
higher BALF IL-1b and IL-6 levels (Figures S2D and S2E) and
increased lung neutrophil infiltration (Figure S2F), consistent
with previous data (Lupfer et al., 2013). In addition, Ripk2/
mice exhibited normal AEC apoptosis (Figure S2G). These re-
sults argue that the Birc3/ mice phenotype is independent of
a deregulation of the autophagy processes controlled by the
NOD2-RIPK2 axis that lead to aberrant caspase-1 activation
and lethality in that system. Altogether, these findings suggest
that cIAP2 likely confers protection to influenza independently
of its function in caspase-1 activation.
Caspase-11-induced pyroptotic cell death, while a defense
strategy against bacterial pathogens that engage type Inc.
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inflammatory disease independently of caspase-1 (Broz et al.,
2012). Caspase-11 was induced by PR/8 infection in both WT
and Birc3/ mice (Figure S2H). To assess to what extent
caspase-11 might influence PR/8-induced lethality, we ob-
tained, from two independent colonies, Birc3/ mice that
were either carriers or not of a passenger intronic inactivating
deletion in the Casp11 gene (Kenneth et al., 2012) and inter-
crossed them to each other. The presence or absence of cas-
pase-11 did not alter the susceptibility of Birc3/ mice, as the
mortality rates between Birc3/Casp11+/+, Birc3/Casp11+/
and Birc3/Casp11/ littermates were not different (Fig-
ure S2I). Additionally, caspase-11 deficiency did not render
mice more susceptible to intranasal infection with a sublethal
dose of a second influenza A strain (H3N2, Figure S2J), unlike
H3N2-infected Birc3/ mice, which had reduced survival (Fig-
ure S2J) as well as increased AEC necrosis on day 7 p.i. (Figures
S2K and S2L). These results exclude a strain-inherent property
related to either increased infectivity and/or pathogenicity of
PR/8 in Birc3/ mice and suggest that the activity of either
caspase-1 or caspase-11 is unlikely to account for the observed
lethality. Collectively, these findings demonstrate that a fraction
of the AEC cell death induced by influenza infection proceeds
independently of the activation of both apoptotic and inflamma-
tory caspases in Birc3/ mice.
Necroptosis Inhibition inBirc3–/– Mice Improves Survival
To test whether necroptosis influenced the progression of influ-
enza-induced lethality, we used the chemical inhibitor Necrosta-
tin (Nec)-1 to block the kinase activity of RIPK1 in vivo, because
RIPK1-deficient mice exhibit early postnatal lethality (Kelliher
et al., 1998). Nec-1 prolonged the survival of Birc3/ mice (Fig-
ure 4A; p = 0.0016) and diminished epithelial cell necrosis and
bronchial degeneration within the airways (Figure 4C), in marked
contrast with the tissue damage observed in vehicle-control-
treated mice (Figure 4B). Concordantly, genetic deletion of
Ripk3 protected Birc3/ mice from PR/8-induced lethality to
levels similar to those of Ripk3/ and WT mice (Figure 4D),
and it restored airway epithelial architecture without impacting
hemorrhage (Figure 4E). This rescue was dependent on Ripk3
deletion from the radio-resistant compartment of Birc3/
mice, since reconstitution of Birc3//Ripk3/ mice with
Ripk3-sufficient hematopoietic cells did not modify resistance
to PR/8 (Table 1). Viral clearance was not affected inmice lacking
Ripk3, as demonstrated by quantification of PR/8 titers in lung
tissues (Figures 4F and 4G). These experiments provided
genetic evidence that necroptosis is not required for effective
antiviral host defense against influenza but, rather, is a patholog-
ical feature that drives elevated morbidity and mortality in
infected Birc3/ mice. To elucidate the potential mechanisms
by which cIAP2 deficiency skews the cell death programs in
AECs toward necroptosis following PR/8 infection, we immuno-
blotted lung homogenates for all known components that enable
RIPK3-dependent necrosis. The short isoform of FLIP (FLIPS)
inhibits apoptosis while actively promoting RIPK3-dependent
necrosis, whereas FLIP long (FLIPL) antagonizes both types of
cell death (Green et al., 2011). Because of higher FLIPS expres-
sion and a decreased FLIPL:FLIPS ratio in lungs of viral-infected
Birc3/ mice (Figure 4H), we hypothesized that lack of cIAP2Cell Hmight promote the formation of the necrosome complex consist-
ing of RIPK1, RIPK3, and FADDduring influenza infection. To test
this, we immunoprecipitated endogenous FADD from lung ex-
tracts and examined the assembly of the necrosome. Although
RIPK3 was constitutively associated with FADD, as previously
reported (Cho et al., 2009), influenza infection led to additional
recruitment of RIPK3 to this FADD complex in Birc3/ mice
compared to WT infected mice (Figure 4I, lanes 10–14 and
5–9; p = 0.0317), whereas virus-dependent interaction of
RIPK1 with FADD was remarkably similar between genotypes
(Figure 4I). In naivemice, a RIPK1-FADD complex spontaneously
assembled upon cIAP2 depletion (Figure 4I, lanes 3 and 4 and 1
and 2), as noted by others (Feoktistova et al., 2011; Tenev et al.,
2011). Our data suggest that cIAP2 deficiency favors the as-
sembly of the necrosome during infection, which translates to
a skewing of cell death toward necroptosis. Pharmacological
depletion of cIAPs in C57BL/6 by treatment with a SMAC
mimetic also resulted in reduced survival to PR/8 infection (Fig-
ures S3A and S3B, related to Figure 4) and a notable increase in
AEC necrosis on day 7 p.i. (Figures S3C and S3D). Altogether,
these data indicate that, following influenza virus infection,
cIAP2 expression in the lung determines, in a cell-specific
fashion, the sensitivity to necroptosis.
Role of Death Ligands in the Development of
Necroptosis-Induced Lethality in Birc3–/– Mice
One function of cIAPs is to act as negative regulators of caspase-
independent Fas-induced cell death (Geserick et al., 2009). We
therefore reasoned that cIAP2 deficiency might affect lung
homeostasis following infection by disturbing DR-mediated
signaling in AECs, rather than through direct virus-induced
sensing or cytopathic effects. Because of the observation that
influenza-induced acute lung injury stems from the absence of
cIAP2 expression in the nonhematopoietic compartment (Fig-
ure 1E and Table 1), and because abrogation of death ligand
expression by immune cells attenuates lung epithelial apoptosis
following influenza virus pneumonia (Herold et al., 2008), we
explored the role of DR signals through bone marrow transplan-
tation experiments. To this end, marrow from Faslgld, Tnfsf10/,
Tnftm1Gkl, and Ltatm1Dch were transferred into irradiated Birc3/
mice to block specific DR signaling (Table 1). Micewith disrupted
Tnf (Figure 5A) or lymphotoxin-a (Figure 5B) signaling developed
influenza-induced lethality with identical kinetics and severity
compared to Birc3/ mice transplanted with WT marrow
(WT/Birc3/), whereas genetic mutation of FasL (Figure 5C)
from the immune compartment had a stronger effect than TRAIL
deficiency (Figure 5D and Table 1) in protecting Birc3/ mice
following PR/8 infection. To address whether direct infection of
AECs was required for necrosis induction in vivo, we analyzed
by FACS the proportion of uninfected AECs (measured as nega-
tive for PR/8 nucleoprotein; Figure 5E) that on day 7 p.i. stained
positive for viability dye uptake without caspase-3 activation
and/or phosphatidylserine translocation. Necrosis was induced
in both uninfected and infected AECs from PR/8-challenged
mice; however, the frequency of necrotic cells in Birc3/ mice
exceeded that in WT mice (Figure 5F), regardless of whether
the cells were infected or not, revealing that skewing of AEC
cell death in the absence of cIAP2 is linked to airway inflamma-
tion rather than direct virus infection of AECs. These dataost & Microbe 15, 23–35, January 15, 2014 ª2014 Elsevier Inc. 27
(legend on next page)
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opposed to direct viral cytopathic effects, are major determi-
nants of mortality triggered by cIAP2 deficiency during influenza
infection.
DISCUSSION
A cell’s decision to self-destruct in response to a virus is irrevers-
ible, and, therefore, in order to be an effective antiviral defense
strategy, it must be tightly controlled to maintain tissue homeo-
stasis during infectious disease. Similar to cell-fate decisions
regulated by XIAP in the liver (Jost et al., 2009), this work iden-
tifies a biological role for cIAP2 as a gatekeeper of pathological
DR-induced activation of cell death during respiratory infection.
We show that cIAP2 regulates death signaling following influenza
infection at the level of the assembly of the necrosome and the
stoichiometry of FLIP isoforms in the lung. RIPK3-dependent
programmed necrosis is the favored cell death mechanism
when the cellular apoptosis machinery is inhibited by FLIPS
(Feoktistova et al., 2011). Other IAPs appear to play nonredun-
dant roles in the infected lung as they were unable to compen-
sate for cIAP2-deficiency, which increased susceptibility to
DR-induced necroptosis independently of pathogen burden or
inflammatory response.
In line with previous in vitro work (Feoktistova et al., 2011;
Tenev et al., 2011), spontaneous assembly of the RIPK1-FADD
ripoptosome under steady-state conditions is insufficient for
cell death induction in vivo. Conceivably, its formation in the
absence of cIAP2 in the lung only preconditions AECs to become
more sensitive to death ligands, with the death-inducing sensi-
tivity of this complex once formed being modulated by the
expression levels of FLIP isoforms, as reported by others (Feok-
tistova et al., 2011; Oberst et al., 2011). Whereas necroptosis
acts as an antiviral mechanism against some DNA viruses (Cho
et al., 2009; Upton et al., 2010), it is dispensable for the control
of influenza replication, arguing for case-specific use of this
death modality during immune defenses to viruses. It is aston-
ishing that a minor switch in the decision of the type of death
by which AECs self-destruct can account for the extensive
epithelium loss that is characteristic ofBirc3/ lungs. But a rela-
tively small increase of 10% in AEC death is sufficient to result
in considerable cell loss over time and leads to severe virus-
induced acute lung injury (Sanders et al., 2013). Necrotic loss
of alveolar type II epithelial cells, which are sensitive to FasL (Ha-
mann et al., 1998) and have an important role in the endogenous
repair capacity of the alveolar epithelium (Wang et al., 2010),Figure 3. Caspase-Independent Cell Death of Birc3–/– AECs during Infl
(A) Tnfa, Tnfsf10, and Fasl expression in infected lungs (*p < 0.05, **p < 0.01; Stud
n = 8–10 mice per genotype per time point).
(B) Active caspase-3-stained lung sections from mock- or PR/8-infected mice (s
genotype for two independent experiments.
(C) Immunoblot analysis of lung tissue at 7 days p.i. (representative of two indep
(D and E) Representative FACS plots of day 7 airway epithelium dead cell number
Live/Dead stain (ViD) and (E) active caspase-3 staining; n = 8–10 mice total per g
(F) FACS quantification of caspase-dependent AEC cell death (mean ±SEM; Man
mice total for each genotype).
(G) CD326-positive cells in the bronchiole lumen of Birc3/ mice are negative
representative of two to three mice per genotype for two independent experime
Cell Hcould compromise repopulation of the injured epithelial lining
and accelerate AEC depletion. Our data also caution that deple-
tion of the cIAPs by synthetic IAP antagonists could adversely
affect individuals who develop respiratory viral infections. Taken
together, these observations favor a model in which cell death
initiation integrates the different stresses that converge on
lowering a cIAP expression threshold that otherwise effectively
prevents pathological RIPK3-dependent necrosis—specifically
during viral infection.
Sensitization of mucosal epithelial cells to TNF-induced nec-
roptotic death plays an important role for the development of
different pathologies in mucosal tissues (Gu¨nther et al., 2011).
Surprisingly, although TNF was upregulated in Birc3/ mice,
development of lethality following influenza infection was
rescued in mice lacking functional FasL or TRAIL signaling rather
than through Tnf/Lta. The potential importance of this pathway in
humans is hinted at by earlier human studies showing that
increased expression of Fas on the alveolar epitheliumwas asso-
ciated with death in cases of acute lung injury (Albertine et al.,
2002). Although we cannot fully exclude that endothelial cell
apoptosis, which was increased in Birc3/ mice, could also be
involved in lesion development and pathogenesis as previously
reported in models of pulmonary hemorrhagic shock (London
et al., 2010; Lu et al., 2004), the rescue of lethality (but not of hem-
orrhaging) through pharmacological inhibition of RIPK1’s kinase
activity or through genetic ablation of Ripk3 suggests that aber-
rant necroptosis accounts for the greater susceptibility of
Birc3/ mice to influenza infection. These observations point
to the existence of context-sensitive and cell-specific death-
inducing ligands and regulatory mechanisms of RIPK3-depen-
dent necroptosis. Distinct from its role in necroptosis, RIPK1
kinase activity stimulates Sp1-dependent transcription of
TNF-a (Christofferson et al., 2012) and promotes IL-1a secretion
in response to deregulated SHP-1 activity in macrophages
(Lukens et al., 2013). Given that deficiency in TNF-a (Damjanovic
et al., 2011) or IL-1R1 signaling (Figure S2) sensitizes the host to
influenza infection, these observations also provide plausible
mechanistic insights as to why genetic codeletion of RIPK3 res-
cuesBirc3/mice, whereas they are only partly rescued by inhi-
bition of RIPK1. However, differentmechanismsmay be at play in
the partial protection offered by Nec-1: aside from its poor phar-
macokinetic characteristics in vivo and its off-target activity
(Degterev et al., 2005), RIPK1 kinase activity also participates in
apoptosis when cIAPs are depleted (Wang et al., 2008), and,
in certain conditions, RIPK3-dependent necroptosis can
occur in the absence of RIPK1 (Vanlangenakker et al., 2011a).uenza Infection
ent’s t test). Data are pooled from two independent experiments (mean ±SEM.;
cale bar indicates 200 mm). Images are representative of two to three mice per
endent experiments). Each lane corresponds to an individual mouse.
s (D), as gated on CD326+CD45CD31Ter119 and defined as positive for the
enotype.
n-Whitney test). Data are pooled from two independent experiments (n = 8–9
for active caspase-3 (white arrows; scale bar indicates 200 mm). Images are
nts. See also Figure S2.
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Table 1. Influenza-Induced Lethality in Bone-Marrow Chimeric cIAP2-Deficient Mice after Intranasal Infection with PR/8 Virus
Survived Died Total Survival
Disadvantage
Survival
Benefit
p Valuea Versus
WT>WT
p Valuea Versus
WT>Birc3/Number % Number % Number
WT>WT 48 72.7 18 27.3 66  
WT>Birc3/ 3 9.1 30 90.9 33 +  <0.0001
WT>Birc3/Ripk3/ 5 54.5 6 45.5 11  + NS 0.0012
WT>Ripk3/ 11 68.8 5 31.3 16  + NS <0.0001
Faslgld > Birc3/ 10 62.5 6 37.5 16  + NS <0.0001
Tnfsf10/>Birc3/ 4 44.4 5 55.6 9  + NS 0.0116
Tnf/>Birc3/ 2 20.0 8 80.0 10 +  0.0011 NS
Lta/>Birc3/ 0 0 6 100 6 +  0.0003 NS
aChi-square test comparing survival distribution at day 14 p.i. with 0.4LD50 of PR/8.
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cIAP2 Maintains Lung Homeostasis during InfectionThe cIAPs have previously been implicated in antiviral immune
signaling. While RNAi depletion of cIAP2 impaired RIG-I-
mediated sensing of Sendai virus or cytoplasmic poly(I:C) (Mao
et al., 2010), we found no intrinsic defect in RIG-I signaling in
primary Birc3/ BMDCs. In fact, we found normal innate and
CD8+ T cell antiviral responses to influenza virus in Birc3/
mice. Moreover, in spite of reduced neutralizing antibody
responses, Birc3/mice had similar lung virus titers to WT con-
trols, establishing that virus replication does not correlate with
the lethal outcome of primary infection and that cIAP2 does
not play an essential part in controlling it. Despite reports of
increased mortality in influenza-infected inflammasome-
deficient mice (Allen et al., 2009; Ichinohe et al., 2009; Thomas
et al., 2009), lethality inCasp1//Casp11/ orNlrp3/ animals
was similar to that ofWT controls, as recently observed by others
(Jamieson et al., 2013). In addition, inflammasome-deficient
mice had either normal or lower necrotic AEC death levels, in
contrast to what was observed for Birc3/ mice. The accumu-
lated evidence reinforces that, in the context of influenza infec-
tion, cIAP2 promotes host resistance independently of its known
roles in caspase-1 activation, immune cell signaling, or
development.
Overall, influenza-induced lethality in Birc3/ mice manifests
primarily as an impairment in DR-induced cell death control that
does not hinder immune-mediated virus control but rather unbal-
ances death ligand signaling output in favor of necrosis of
infected but also of bystander uninfected cells. This is consistentFigure 4. Inhibiting RIPK3-Dependent Programmed Necrosis Prevents
(A) Survival rate of infected Birc3/ mice treated with Nec-1 or vehicle intrape
experiments.
(B and C) H&E-stained lung cross-sections of Birc3/ vehicle-treated (B) and N
within the bronchioles (arrow head: erosion). Insets correspond to the boxed re
mouse from two independent experiments with n = 3–4 mice per group.
(D) Survival rate of Birc3/, Birc3/Ripk3/, Ripk3/ and WT mice to PR/8 in
(E) H&E-stained lung cross-sections on 11 days p.i. Data are representative of tw
scale.
(F) Viral loads by plaque assay (mean ±SD; n = 4 mice per genotype per time po
(G) Lung sections stained for PR/8 antigens (scale bar indicates 50 mm).
(H) Immunoblot analysis of necrosome component expression in lung tissue from
individual mouse. Densitometry analysis using ImageJ software (mean ±SEM; n =
infected mice per genotype; *p = 0.0315, Mann-Whitney test).
(I) Formation of the necrosome on 7 days p.i. Asterix denotes (IgGH) heavy chains.
FADD ratio is shown at the bottom. See also Figure S3.
Cell Hwith the concept that insufficient host defense to infectious dis-
ease can be due to an impaired ability to tolerate tissue damage
(Medzhitov et al., 2012). In this context, we envisage that the
transcriptional induction of cIAP2 by inflammatory triggers
(Wang et al., 1998) may have evolved to ensure survival of critical
cell types in response to strong DR signals induced by inflamma-
tion. The fact that the lethality from viral-induced necrosis in the
context of cIAP2 deficiency is found for two different influenza
strains points to a more general mechanism that is not specific
to a single virus and, thus, is likely of broader relevance for our
understanding of the mechanisms that are engaged during
airway inflammation to maintain tissue homeostasis and host
fitness. Indeed, DR-mediated lung epithelial injury is not
restricted to influenza virus, as it also occurs during infection
with other respiratory RNA viruses (Bem et al., 2010). Therefore,
continued characterization of cytoprotective tolerance mecha-
nisms, like the one described here during influenza infection,
may provide novel entry points for therapeutics against acute
lung injury.
EXPERIMENTAL PROCEDURES
Reagents
ELISA kits for anti-CXCL10 (DY466) were from R&D and VeriKine anti-IFNa
(42120) were from PBL; anti-caspase-8 Asp387 (9429) and anti-cFLIP (3210)
from Cell Signaling Technology; anti-FADD (M-19) was from Santa Cruz;
anti-RIPK1 (610459) was from BD Transduction Laboratories; anti-RIPK3
(PSC-2283) was from Axxora; anti-active caspase-3 (AF835) was from R&D;Influenza-Induced Lethality in Birc3–/– Mice
ritoneally daily starting on 3 days p.i. Data are pooled from two independent
ec-1-treated (C) mice on 7 days p.i. Black arrow indicates epithelial shedding
gions (enlarged by an 8.53 zoom). Each section corresponds to an individual
fection. Data are pooled from two independent experiments.
o independent experiments with n = 3–4 mice per group. All H&E are to 25 mm
int).
PR/8-infected mice (lysates used in immunoprecipitation in (I). Each lane is an
3 independent experiments with each two to three uninfected and four to five
Each lane is an individual mouse. Densitometry analysis of RIPK1 and RIPK3 to
ost & Microbe 15, 23–35, January 15, 2014 ª2014 Elsevier Inc. 31
Figure 5. FasL and TRAIL Are Required for Influenza-Induced
Lethality in Birc3–/– Mice
(A–D) Survival rate of chimeric mice after PR/8 infection. Data are pooled from
two independent experiments in (D).
(E) Representative FACS plots of infected (NP+) versus noninfected
(NP) AECs.
(F) FACS quantification of cell-death type (necrosis, open circles; apoptosis,
closed circles) after 7 days p.i. in infected (NP+) versus uninfected (NP) AECs
from the same mouse. Necrosis (open circles) is defined as annexin V, active
caspase-3 and ViD+; apoptosis (closed circles) is defined as annexin V+,
active caspase-3+, and ViD+/. Lines and bars represent the mean and SD
(n = 5–6 mice per genotype, *p < 0.05; **p < 0.001; Student’s two-tailed t test).
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32 Cell Host & Microbe 15, 23–35, January 15, 2014 ª2014 Elsevier Ianti-influenza A,B (M149) was from Takara Bio; anti-CD326 (G8.8), anti-active
caspase-3-PE (C92-605), and streptavidin APCCy7 were from BD Biosci-
ences; Alexa Fluor-594 or Alexa Fluor647 anti-rabbit or rat antibodies were
from Molecular Probes/Life Technologies; anti-CD31-APC (390), anti-CD45-
PECy7 (30-F11), anti-CD326-PerCP-eFluor710 (G8.8), and anti-Ter119 were
from eBioscience; anti-influenza A virus nucleoprotein-FITC (431) was from
Abcam; PR/8 was from Charles River; Nec-1 (N9037), BSA-FITC (A9771),
and protein G sepharose beads (P3296) were from Sigma-Aldrich; Smac-
mimetic LCL-161 (A-1147)was from Active Biochem; and SURFLO I.V.
20G31’ catheter (SR-0X2025CA) was from Terumo (Elkton).
Mice
All mice were maintained at McGill University and were previously described
(Conte et al., 2006; Glaccum et al., 1997; Kobayashi et al., 2002; Kuida
et al., 1995; Mariathasan et al., 2004, 2006; Newton et al., 2004).
Birc3/Ripk3/ mice were generated through intercrossing. B6Smn.C3-
Faslgld/J (001021), B6.129S-Tnftm1Gkl/J (005540), B6.129S2-Ltatm1Dch/J
(002258), and B6.SJL-PtprcaPep3b/BoyJ (CD45.1 congenics, 002014) were
from The Jackson Laboratory. Tnfsf10/ mice from Amgen (Seattle) (Sedger
et al., 2002) were maintained at the University of Minnesota. Animals were
used at 6–8 weeks old or 12–13 weeks old for the chimeras. All animal exper-
iments were approved by the McGill University Animal Care and Ethics
Committee in accordance with the guidelines of the Canadian Council on
Animal Care.
Chimeras
Mice lethally irradiated with a dose of 1,000 rads on a X-Ray RS-2000 Biolog-
ical irradiator were injected intravenously with red blood cell-depleted bone
marrow from the indicated sex-matched donors. The extent of engraftment
was verified after 6 weeks by FACS staining of blood lymphocytes with
anti-CD45 and anti-B220 and by genotyping. In control experiments
using congenic CD45.1 and CD45.2 mice, chimerism was usually found to
beR98% as assessed in the lung and blood.
Virus Infection and Lung Tissue Sampling
Age- and sex-matched mice were anesthetized intramuscularly with xylazine
and ketamine and infected intranasally with a sublethal (0.4LD50; 12.9 HAU/
mouse) weight-adjusted dose of PR/8 in 15 ml of PBS. Where indicated,
Nec-1 was administered daily intraperitoneally at 5 mg kg1 on days 3–14
p.i. LCL-161 was administered by oral gavage twice weekly at 50 mg kg1
or otherwise stated in figure legends. After euthanasia by CO2, the trachea
was exposed, cannulated, and BAL was collected by injecting and pooling
two volumes of 0.5 ml cold, sterile PBS. The left lung lobes were used for
histopathological analysis. The right lungs were used for RNA isolation and/
or homogenized and sonicated in B150 buffer (20 mM Tris-HCl [pH 8.0],
150 mM KCl, 10% glycerol, 5 mM MgCl2, and 0.1% NP-40 supplemented
with a protease inhibitor cocktail [11836153001; Roche] and phosphatase
inhibitors), followed by boiling in Laemmli sample buffer for immunoblot. For
epithelial integrity measurements, BSA-FITC was administered intravenously
at 1 mg kg1 2 hr before killing, following which fluorescence content in
BALF was measured on a FluoStar OPTIMA at 420 nm absorbance and
520 nm emission wavelengths.nc.
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Lung lobes were collected in 10% neutral-buffered formalin, and tissue
sections were prepared from paraffin block and stained with H&E. Immuno-
fluorescence slides were analyzed on a Zeiss Axioskop upright wide-field
microscope (2030.5 or 403/0.75 Plan-Neofluar objectives) equipped with a
high-resolution monochromatic AxioCam HRm camera and driven by
AxioVision version 4.9.1 (Carl Zeiss Microscopy).
qPCR
Total lung RNA was extracted using Trizol reagent, and reverse transcription
was performed on 1 mg total RNA in a final volume of 20 ml using random
hexamers and the M-MLV RT kit (all from Invitrogen). qPCR reactions were
performed using 2 ml of cDNA, 12.5 ml of the iTaq SYBR green supermix
(Biorad), and 5 mM of each primer (Table S1) in a total volume of 25 ml. An
ABI PRISM 7900 Sequence Detection System (Applied Biosystems)
programmed with an initial step of 3 min at 95C, followed by 45 cycles of
15 s at 95C, 30 s at 57C and 33 s at 72C. All reactions were run in duplicate,
averaged, and normalized to the housekeeping gene L32 to quantify the
relative gene expression from that of the mock-infected control using the
2DDCT method.
Virus Titration by Plaque-Forming Unit Assay
Serial dilutions of lung homogenates were performed in PBS and used to infect
confluent MDCK cells for 1 hr at 37C and 5% CO2. Following this period, the
mediumwas replacedwith 0.65%agarose in DMEMcontaining 0.2%BSA and
1 mg/ml TPCK-treated trypsin (Worthington). Infection was pursued for
3–4 days, and plaques were visualized by crystal violet staining.
Immunoprecipitation
For endogenous coimmunoprecipitation studies, whole-lung lysates (1 mg
protein) in B150 were cleared by incubation with protein G beads, incubated
with 1.5 mg anti-FADD antibodies for 2.5 hr at 4C, and protein G beads
were added for an additional hour. Immunoprecipitates were eluted by boiling
in Laemmli buffer, electrophoresed on 10% SDS polyacrylamide gels, and
processed for immunoblot analysis using antibodies to mouse RIPK1,
RIPK3, and FADD.
FACS Assays
Collagenase-digested lung cells were surface stained with the appropriate
fluorochrome-labeled antibodies and the amine reactive viability dye LIVE/
DEAD aqua fixable stain (ViD, Molecular Probes) for 20 min in the dark at
4C. Annexin V-eFluor450 (eBioscience) was added for 15 min at room
temperature after cell-surface FACS staining, followed by intracellular staining
for active caspase-3 and anti-influenza nucleoprotein, after which cells were
fixed in PBS containing 1% formaldehyde and stored at 4C in the dark until
FACS analysis. Data were acquired on a Canto instrument (BD Biosciences)
equipped for the detection of eight fluorescent parameters. Data analysis
was performed using FACS DiVa version 6.0 software.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software v5.0 and
SigmaPlot 12 statistical package. Data are represented as mean ± SD or
SEM. Comparisons between groups were performed with a two-tailed
Student’s t test or Mann-Whitney U test, one-way ANOVA test, or chi-square
test. Survival curves were analyzed with a log rank test.
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